Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Erythritol triggers expression of virulence traits in Brucella melitensis.

Petersen E, Rajashekara G, Sanakkayala N, Eskra L, Harms J, Splitter G.

Microbes Infect. 2013 Jun;15(6-7):440-9. doi: 10.1016/j.micinf.2013.02.002. Epub 2013 Feb 16.

2.

Differential expression of iron acquisition genes by Brucella melitensis and Brucella canis during macrophage infection.

Eskra L, Covert J, Glasner J, Splitter G.

PLoS One. 2012;7(3):e31747. doi: 10.1371/journal.pone.0031747. Epub 2012 Mar 5.

3.

Brucella melitensis, B. neotomae and B. ovis elicit common and distinctive macrophage defense transcriptional responses.

Covert J, Mathison AJ, Eskra L, Banai M, Splitter G.

Exp Biol Med (Maywood). 2009 Dec;234(12):1450-67. doi: 10.3181/0904-RM-124.

4.

Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.

Durward MA, Harms J, Magnani DM, Eskra L, Splitter GA.

Infect Immun. 2010 Jan;78(1):168-76. doi: 10.1128/IAI.00994-09. Epub 2009 Nov 2.

5.

Genomic island 2 of Brucella melitensis is a major virulence determinant: functional analyses of genomic islands.

Rajashekara G, Covert J, Petersen E, Eskra L, Splitter G.

J Bacteriol. 2008 Sep;190(18):6243-52. doi: 10.1128/JB.00520-08. Epub 2008 Jul 18.

6.

Brucella: functional genomics and host-pathogen interactions.

Rajashekara G, Eskra L, Mathison A, Petersen E, Yu Q, Harms J, Splitter G.

Anim Health Res Rev. 2006 Jun-Dec;7(1-2):1-11. Review.

PMID:
17389050
7.

Unraveling Brucella genomics and pathogenesis in immunocompromised IRF-1-/- mice.

Rajashekara G, Krepps M, Eskra L, Mathison A, Montgomery A, Ishii Y, Splitter G.

Am J Reprod Immunol. 2005 Dec;54(6):358-68.

PMID:
16305661
8.

Isolation of Brucella abortus total RNA from B. abortus-infected murine RAW macrophages.

Covert J, Eskra L, Splitter G.

J Microbiol Methods. 2005 Mar;60(3):383-93.

PMID:
15649540
9.

Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus.

Eskra L, Mathison A, Splitter G.

Infect Immun. 2003 Mar;71(3):1125-33.

10.

Brucella abortus genes identified following constitutive growth and macrophage infection.

Eskra L, Canavessi A, Carey M, Splitter G.

Infect Immun. 2001 Dec;69(12):7736-42.

11.

Bovine herpesvirus-1 infects activated CD4+ lymphocytes.

Eskra L, Splitter GA.

J Gen Virol. 1997 Sep;78 ( Pt 9):2159-66.

PMID:
9292002
12.
13.

The bovine p150/95 molecule (CD11c/CD18) functions in primary cell-cell interaction.

Eskra L, O'Reilly KL, Splitter GA.

Vet Immunol Immunopathol. 1991 Sep;29(3-4):213-27.

PMID:
1683051
14.

Individual antigens of cattle. Antibodies to non-clustered bovine antigens.

O'Reilly KL, Eskra L, Splitter GA.

Vet Immunol Immunopathol. 1991 Jan;27(1-3):91-3. No abstract available.

PMID:
2021069
15.

Biochemical analysis of bovine T cell antigens with workshop monoclonal antibodies.

O'Reilly KL, Eskra L, Splitter GA.

Vet Immunol Immunopathol. 1991 Jan;27(1-3):223-9.

PMID:
2021063
16.

Summary of workshop findings for leukocyte antigens of cattle.

Howard CJ, Morrison WI, Bensaid A, Davis W, Eskra L, Gerdes J, Hadam M, Hurley D, Leibold W, Letesson JJ, et al.

Vet Immunol Immunopathol. 1991 Jan;27(1-3):21-7. No abstract available.

PMID:
1902342
17.

Effect of monoclonal antibodies on in vitro function of T-cell subsets.

Eskra L, O'Reilly KL, Splitter GA.

Vet Immunol Immunopathol. 1991 Jan;27(1-3):215-22.

PMID:
1826982
18.
19.
20.

Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues.

Zarling JM, Schlais J, Eskra L, Greene JJ, Ts'o PO, Carter WA.

J Immunol. 1980 Apr;124(4):1852-7. No abstract available.

PMID:
6154082
21.

Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.

Zarling JM, Eskra L, Borden EC, Horoszewicz J, Carter WA.

J Immunol. 1979 Jul;123(1):63-70. No abstract available.

PMID:
286738
22.

Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.

Zarling JM, Sosman J, Eskra L, Borden EC, Horoszewicz JS, Carter WA.

J Immunol. 1978 Nov;121(5):2002-4.

PMID:
309487

Supplemental Content

Support Center